These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38500630)

  • 1. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as novel HIV-1 integrase strand transfer inhibitors.
    Zhang RH; Chen GQ; Wang W; Wang YC; Zhang WL; Chen T; Xiong QQ; Zhao YL; Liao SG; Li YJ; Yan GY; Zhou M
    RSC Adv; 2024 Mar; 14(13):9020-9031. PubMed ID: 38500630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors.
    Wang YC; Zhang WL; Zhang RH; Liu CH; Zhao YL; Yan GY; Liao SG; Li YJ; Zhou M
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants.
    Smith SJ; Zhao XZ; Passos DO; Pye VE; Cherepanov P; Lyumkis D; Burke TR; Hughes SH
    ACS Infect Dis; 2021 Jun; 7(6):1469-1482. PubMed ID: 33686850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor JTP-0157602.
    Ohata Y; Tomonaga M; Watanabe Y; Tomura K; Kimura K; Akaki T; Adachi K; Kodama EN; Matsuzaki Y; Hayashi H
    J Virol; 2022 Mar; 96(6):e0184321. PubMed ID: 35045265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors.
    Hassounah SA; Mesplède T; Quashie PK; Oliveira M; Sandstrom PA; Wainberg MA
    J Virol; 2014 Sep; 88(17):9683-92. PubMed ID: 24920794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants.
    Smith SJ; Zhao XZ; Burke TR; Hughes SH
    Retrovirology; 2018 May; 15(1):37. PubMed ID: 29769116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
    Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
    J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis and systematic review of the efficacy and resistance for human immunodeficiency virus type 1 integrase strand transfer inhibitors.
    Yang LL; Li Q; Zhou LB; Chen SQ
    Int J Antimicrob Agents; 2019 Nov; 54(5):547-555. PubMed ID: 31398480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural effects of HIV-1 subtype C integrase mutations on the activity of integrase strand transfer inhibitors in South African patients.
    Mbhele N; Gordon M
    J Biomol Struct Dyn; 2022; 40(23):12546-12556. PubMed ID: 34488561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput Screening.
    Aknin C; Smith EA; Marchand C; Andreola ML; Pommier Y; Metifiot M
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31614773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance.
    Richetta C; Tu NQ; Delelis O
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.
    Engelman AN
    J Biol Chem; 2019 Oct; 294(41):15137-15157. PubMed ID: 31467082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
    Henerico S; Lyimo E; Makubi AN; Magesa D; Desderius B; Mueller A; Changalucha J; Kalluvya SE; Van Zyl G; Preiser W; Mshana SE; Kasang C
    J Antimicrob Chemother; 2022 Oct; 77(11):3138-3143. PubMed ID: 36101479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
    Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
    Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors.
    Weber J; Rose JD; Vazquez AC; Winner D; Margot N; McColl DJ; Miller MD; Quiñones-Mateu ME
    PLoS One; 2013; 8(6):e65631. PubMed ID: 23776513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239.
    Hassounah SA; Liu Y; Quashie PK; Oliveira M; Moisi D; Brenner BG; Sandstrom PA; Mesplède T; Wainberg MA
    J Virol; 2015 Dec; 89(23):12002-13. PubMed ID: 26378179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
    De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 4-Oxo-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors: Synthesis, Docking Studies, Molecular Dynamics Simulation and Biological Activities.
    Zadeh EE; Vahabpour R; Beirami AD; Hajimahdi Z; Zarghi A
    Med Chem; 2021; 17(9):1060-1071. PubMed ID: 32901587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant Mutants.
    Smith SJ; Zhao XZ; Burke TR; Hughes SH
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.